核心期刊论文：

1. Liu L, Liang L, Mai G, Chen Y: A novel fatty acid metabolism-related gene signature predicts the prognosis, tumor immune properties, and immunotherapy response of colon adenocarcinoma patients. FASEB Bioadv 2022, 4(9):585-601.1
2. Hu W, Chen ZM, Li XX, Lu L, Yang GH, Lei ZX, You LJ, Cui XB, Lu SC, Zhai ZY et al: Faecal microbiome and metabolic signatures in rectal neuroendocrine tumors. Theranostics 2022, 12(5):2015-2027.1（IF=11.6）
3. Yan Y, Peng X, Chen Y: [Fecal microbiota transplantation in the treatment of acute intestinal pseudo obstruction secondary to intracerebral hemorrhage: a case report and literature review]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2022, 34(3):306-310.1
4. Wang Z, Wang Z, Wang Y, Wu J, Yu Z, Chen C, Chen J, Wu B, Chen Y: High risk and early onset of cancer in Chinese patients with Peutz-Jeghers syndrome. Front Oncol 2022, 12:900516.1（IF=5.738）
5. Wang Y, Wang Z, Yang H, Chen S, Zheng D, Liu X, Jiang Q, Chen Y: Metformin Ameliorates Chronic Colitis-Related Intestinal Fibrosis via Inhibiting TGF-β1/Smad3 Signaling. Front Pharmacol 2022, 13:887497.1（IF=5.988）
6. Wang S, Deng W, Li F, Xiang L, Lv P, Chen Y: Treatment with butyrate alleviates dextran sulfate sodium and Clostridium difficile-induced colitis by preventing activity of Th17 cells via regulation of SIRT1/mTOR in mice. J Nutr Biochem 2022, 111:109155.1（IF=6.117）
7. Lin M, Li Z, Lin Q, Wang P, Liu W, Yuan J, Hong Z, Chen Y: Development and clinical application of a rapid and visual loop-mediated isothermal amplification test for tetM gene in Clostridioides difficile strains cultured from feces. Int J Infect Dis 2022, 122:676-684.1（IF=12.073）
8. Liang L, Yang C, Liu L, Mai G, Li H, Wu L, Jin M, Chen Y: Commensal bacteria-derived extracellular vesicles suppress ulcerative colitis through regulating the macrophages polarization and remodeling the gut microbiota. Microb Cell Fact 2022, 21(1):88.（IF=6.352）
9. Liang L, Mai S, Mai G, Chen Y, Liu L: DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma. Front Endocrinol (Lausanne) 2022, 13:882431.1（IF=6.055）
10. Liang L, Liu L, Zhou W, Yang C, Mai G, Li H, Chen Y: Gut microbiota-derived butyrate regulates gut mucus barrier repair by activating the macrophage/WNT/ERK signaling pathway. Clin Sci (Lond) 2022, 136(4):291-307.1（IF=6.876）
11. Li Z, Ke H, Lin Q, Shen Z, Chen Y: Global trends in gut microbiota and clostridioides difficile infection research: A visualized study. J Infect Public Health 2022, 15(7):806-815.1（IF=7.537）
12. Deng W, Wang S, Li F, Wang F, Xing YP, Li Y, Lv Y, Ke H, Li Z, Lv PJ et al: Gastrointestinal symptoms have a minor impact on autism spectrum disorder and associations with gut microbiota and short-chain fatty acids. Front Microbiol 2022, 13:1000419.1（IF=6.064）
13. Zhou Y, He Y, Liu L, Zhou W, Wang P, Hu H, Nie Y, Chen Y. Alterations in Gut Microbial Communities Across Anatomical Locations in Inflammatory Bowel Diseases. Front Nutr. 2021 Feb 26;8:615064. doi: 10.3389/fnut.2021.615064. PMID: 33718417; PMCID: PMC7952524.（IF=6.589）
14. Yang C, Liang L, Lv P, Liu L, Wang S, Wang Z, Chen Y. Effects of non-viable Lactobacillus reuteri combining with 14-day standard triple therapy on Helicobacter pylori eradication: A randomized double-blind placebo-controlled trial. Helicobacter. 2021 Oct 10:e12856. doi: 10.1111/hel.12856. Epub ahead of print. PMID: 34628695.（IF=5.182）
15. Liu L, Liang L, Yang C, Zhou Y, Chen Y. Extracellular vesicles of Fusobacterium nucleatum compromise intestinal barrier through targeting RIPK1-mediated cell death pathway. Gut Microbes. 2021 Jan-Dec;13(1):1-20. doi: 10.1080/19490976.2021.1902718. PMID: 33769187; PMCID: PMC8007154. （IF=9.434）
16. Zhou W, Wang M, Liang L, Liu L, Zheng D, Silvester JA, Ma W, Wu W, Ji G, Xu Y, Xu X, Kelly CP, Chen Y. Prevalence of Celiac Disease in China: Meta-analysis and Serological Survey in High-risk Populations. J Dig Dis. 2021 Sep 5. doi: 10.1111/1751-2980.13049. Epub ahead of print. PMID: 34482631.（IF=3.366）
17. Ke H, Li J, Lu B, Yang C, Wang J, Wang Z, Liu L, Chen Y. The appropriate cutoff gastric pH value for Helicobacter pylori eradication with bismuth-based quadruple therapy. Helicobacter. 2021 Feb;26(1):e12768. doi: 10.1111/hel.12768. Epub 2020 Oct 21. PMID: 33089598.（IF=5.182）
18. L. Zeng, J. Tan, M. Xue, L. Liu, M. Wang, L. Liang, J. Deng, W. Chen, and Y. Chen, An engineering probiotic producing defensin-5 ameliorating dextran sodium sulfate-induced mice colitis via Inhibiting NF-kB pathway. Journal of translational medicine. 2020;18(1):107.（IF=8.439）
19. F. Li, R. Xu, C. L. Lin, B. E. Low, L. Cai, S. Li, P. Ji, L. Huang, M. V. Wiles, Y. A. Hannun, L. M. Obeid, Y. Chen, and C. Mao，Maternal and fetal alkaline ceramidase 2 is required for placental vascular integrity in mice. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2020;34(11):15252-68.（IF=5.833）
20. Ming-Yue Wu, Le Liu, Er-Jin Wang, Hai-Tao Xiao, Cui-Zan Cai, Jing Wang,Huanxing Su, Yitao Wang, Jieqiong Tan, Zhuohua Zhang, Juan Wang, Maojing,Yao,De-Fang Ouyang, Zhenyu Yue, Min Li, Ye Chen, Zhao-Xiang Bian,Jia-Hong Lu: PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation. Autophagy.2020;190(13)（IF=13.391）
21. Haoran Ke1 | Jing Li1,2 | Bingyun Lu1,3 | Chenghai Yang1 | Jiamin Wang1,4 |Zhiqing Wang1 | Le Liu1 | Ye Chen1; The appropriate cutoff gastric pH value for Helicobacter pylori. Helicobacter;2020;216(1)（IF=5.182）
22. Wang S, Lv D, Jiang S, Jiang J, Liang M, Hou F,Chen Y: Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease.Clinical Science 2019;133:1857-1870.（IF=6.876）
23. Lu B, Wang J, Li J, Liu L, Chen Y: Half-dose clarithromycin-containing bismuth quadruple therapy is effective and economical in treating helicobacter pylori infection: A single-center, open-label, randomized trial. Helicobacter 2019;24:e12566.（IF=5.182）
24. Liu L, Liang L, Liang H, Wang M, Lu B, Xue M, Deng J, Chen Y: Fusobacterium nucleatum aggravates the progression of colitis by regulating m1 macrophage polarization via akt2 pathway. Frontiers in immunology 2019;10:1324.（IF=8.786）
25. Zhou Y, Xu ZZ, He Y, Yang Y, Liu L, Lin Q, Nie Y, Li M, Zhi F, Liu S, Amir A, González A, Tripathi A, Chen M, Wu GD, Knight R, Zhou H, Chen Y: Gut microbiota offers universal biomarkers across ethnicity in inflammatory bowel disease diagnosis and infliximab response prediction. mSystems 2018;3（IF=7.324）
26. Deng J, Zeng L, Lai X, Li J, Liu L, Lin Q, Chen Y: Metformin protects against intestinal barrier dysfunction via ampkα1-dependent inhibition of jnk signalling activation. Journal of cellular and molecular medicine 2018;22:546-557.（IF=5.295）
27. Jiang S, Xie S, Lv D, Wang P, He H, Zhang T, Zhou Y, Lin Q, Zhou H, Jiang J, Nie J, Hou F, Chen Y: Alteration of the gut microbiota in chinese population with chronic kidney disease. Scientific reports 2017;7:2870.（IF=4.995）
28. Zhang Y, Wang Z, Liu J, Zhang S, Fei J, Li J, Zhang T, Wang J, Park PW, Chen Y: Cell surface-anchored syndecan-1 ameliorates intestinal inflammation and neutrophil transmigration in ulcerative colitis. Journal of cellular and molecular medicine 2017;21:13-25.（IF=5.295）
29. Zhang Y, Wang Z, Liu J, Zhang Z, Chen Y: Suppressing syndecan-1 shedding ameliorates intestinal epithelial inflammation through inhibiting nf-κb pathway and tnf-α. 2016;2016:6421351.（IF=1.919）
30. Jiang S, Xie S, Lv D, Zhang Y, Deng J, Zeng L, Chen Y: A reduction in the butyrate producing species roseburia spp. And faecalibacterium prausnitzii is associated with chronic kidney disease progression. Antonie van Leeuwenhoek 2016;109:1389-1396.（IF=2.158）
31. Zhang T, Lin QY, Fei JX, Zhang Y, Lin MY, Jiang SH, Wang P, Chen Y: Clostridium difficile infection worsen outcome of hospitalized patients with inflammatory bowel disease. Scientific reports 2016;6:29791.（IF=4.995）
32. Zhou Y, Chen H, He H, Du Y, Hu J, Li Y, Li Y, Zhou Y, Wang H, Chen Y, Nie Y: Increased enterococcus faecalis infection is associated with clinically active crohn disease. Medicine 2016;95:e5019.（IF=1.817）
33. Lin M, Liu W, Wang P, Tan J, Zhou Y, Wu P, Zhang T, Yuan J, Chen Y: Rapid detection of ermb gene in clostridium difficile by loop-mediated isothermal amplification. Journal of medical microbiology 2015;64:854-861.（IF=3.196）
34. Wang Z, Li R, Tan J, Peng L, Wang P, Liu J, Xiong H, Jiang B, Chen Y: Syndecan-1 acts in synergy with tight junction through stat3 signaling to maintain intestinal mucosal barrier and prevent bacterial translocation. Inflammatory bowel diseases 2015;21:1894-1907.（IF=7.290）
35. Zhou Y, He H, Wang P, Zhang T, Lin M, Wang H, Nie Y, Chen Y: Infliximab for the treatment of crohn's disease: Efficacy and safety in a chinese single-center retrospective study. European journal of gastroenterology & hepatology 2015;27:1270-1275.（IF=2.586）
36. Zhou YL, Xie S, Wang P, Zhang T, Lin MY, Tan JS, Zhi FC, Jiang B, Chen Y: Efficacy and safety of infliximab in treating patients with ulcerative colitis: Experiences from a single medical center in southern china. Journal of digestive diseases 2014;15:483-490.（IF=3.366）
37. Wang P, Zhou Y, Wang Z, Xie S, Zhang T, Lin M, Li R, Tan J, Chen Y, Jiang B: Identification of clostridium difficile ribotype 027 for the first time in mainland china. Infection control and hospital epidemiology 2014;35:95-98.（IF=6.520）
38. Wang XF, Li AM, Li J, Lin SY, Chen CD, Zhou YL, Wang X, Chen CL, Liu SD, Chen Y: Low molecular weight heparin relieves experimental colitis in mice by downregulating il-1β and inhibiting syndecan-1 shedding in the intestinal mucosa. PloS one 2013;8:e66397.（IF=3.752）
39. Zhang S, Qing Q, Wang Q, Xu J, Zhi F, Park PW, Zhang Y, Chen Y: Syndecan-1 and heparanase: Potential markers for activity evaluation and differential diagnosis of crohn's disease. Inflammatory bowel diseases 2013;19:1025-1033.（IF=7.290）
40. Zhang S, Qing Q, Bai Y, Mao H, Zhu W, Chen Q, Zhang Y, Chen Y: Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: A systematic review and meta-analysis. Digestive diseases and sciences 2013;58:1991-2000.（IF=3.486）
41. Wang X, Chen Y, Song Y, Zhang S, Xie X, Wang X: Activated syndecan-1 shedding contributes to mice colitis induced by dextran sulfate sodium. Digestive diseases and sciences 2011;56:1047-1056.（IF=3.486）
42. Ma F, Chen Y, Li J, Qing HP, Wang JD, Zhang YL, Long BG, Bai Y: Screening test for anti-helicobacter pylori activity of traditional chinese herbal medicines. World journal of gastroenterology 2010;16:5629-5634.（IF=5.374）
43. Hayashida K, Chen Y, Bartlett AH, Park PW: Syndecan-1 is an in vivo suppressor of gram-positive toxic shock. The Journal of biological chemistry 2008;283:19895-19903.
44. Chen Y, Götte M, Liu J, Park PW: Microbial subversion of heparan sulfate proteoglycans. Molecules and cells 2008;26:415-426.（IF=4.250）
45. Chen Y, Hayashida A, Bennett AE, Hollingshead SK, Park PW: Streptococcus pneumoniae sheds syndecan-1 ectodomains through zmpc, a metalloproteinase virulence factor. The Journal of biological chemistry 2007;282:159-167.
46. Tang W, Pei M, Li J, Xu N, Xiao W, Yu Z, Zhang J, Hong L, Guo Z, Lin J, Dai W, Xiao Y, Wu X, Liu G, Zhi F, Li G, Xiong J, Chen Y, Zhang H, Xiang L, Li A, Liu S, Wang J: The miR-3648/FRAT1-FRAT2/c-Myc negative feedback loop modulates the metastasis and invasion of gastric cancer cells. Oncogene 2022;41(43), 4823-4838.（IF=8.765）
47. Li Z, Ke H, Wang Y, et al. Global trends in Akkermansia muciniphila research: A bibliometric visualization. Front Microbiol. 2022;13:1037708. （IF=6.06）
48. 杨荟平, 王志青, 刘乐, 等. 炎症性肠病中应用益生菌的临床疗效与潜在风险[J]. 中华炎性肠病杂志, 2022,06(2):155-160.